|
|
|
Search
06/25/2020 Paul Kesselman, DPM
DEA Fee Proposes Increase of 21%
If things were not financially taxing for all providers right now, the government has found another instrument to take some hard-earned money from healthcare practitioners and any entity involved in the distribution or manufacturing of controlled substances.
The DEA is now proposing a 21% increase ($731 to $838) for the triennial registration. This is especially outrageous for many podiatrists or healthcare providers who have chosen to discontinue performing procedures or seeing patients where prescribing controlled substances may be required.
Attempts to dis-enroll from the DEA at the time of registration will be met with many emails and letters from your networked carriers who will want to know proof of DEA enrollment and re- registration or the name of the doctor who will write those prescriptions for your patients.
It is terribly unfair for the DEA to continue to increase the cost of practicing, particularly to those providers who no longer wish to prescribe narcotics.
There should be a method by which insurance carriers do not further penalize physicians who choose not to prescribe narcotics because they elect not to renew a DEA license. To provide another doctor's name as your covering doctor who will write narcotic prescriptions places an undue burden on that physician and places them in a precarious position. If you cannot write narcotic prescriptions, because you elect not to, you most certainly should not be performing certain surgeries or seeing specific types of patients.
The additional raise in the fee also is accompanied by the inability for a refund once paid, should you choose to retire from practice, become disabled or any attempt for your estate to recover any payments should you pass away.
I am interested in hearing from other semi- retired podiatrists or health care providers who may share these concerns/opinions or have some alternative solutions.
Paul Kesselman, DPM, Oceanside, NY
There are no more messages in this thread.
|
|
|
|